Oppenheimer Reaffirms Their Buy Rating on Catalyst Pharma (CPRX)

In a report released yesterday, Leland Gershell from Oppenheimer maintained a Buy rating on Catalyst Pharma (CPRX – Research Report), with a price target of $10.00. The company’s shares closed last Wednesday More »

Abbott Labs (ABT) Gets a Buy Rating from Wells Fargo

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Labs (ABT – Research Report) yesterday. The company’s shares closed last Wednesday at $84.95. According to TipRanks.com, Biegelsen is a 5-star More »